1221793-42-5 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid is employed as a synthetic intermediate for the development of pharmaceuticals. Its unique structure, including the difluorinated piperidine ring and the Boc protecting group, contributes to the design of novel drug candidates with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid is used as a key component in the synthesis of biologically active compounds. Its presence in molecules can influence their pharmacokinetic and pharmacodynamic properties, making it a valuable tool for the exploration of new therapeutic agents.
Used in Organic Synthesis:
1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid is utilized as a versatile building block in organic synthesis. The Boc protecting group allows for selective reactions to occur at other sites on the molecule, while the difluorinated piperidine ring can participate in various chemical transformations, broadening the scope of synthetic applications.
Used in the Development of Biologically Active Molecules:
1-(tert-butoxycarbonyl)-4,4-difluoropiperidine-2-carboxylic acid is used as a structural element in the design of biologically active molecules. The difluorination of the piperidine ring can modulate the molecule's lipophilicity, metabolic stability, and binding affinity, which are crucial factors in the development of effective drugs and other bioactive compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1221793-42-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,1,7,9 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1221793-42:
(9*1)+(8*2)+(7*2)+(6*1)+(5*7)+(4*9)+(3*3)+(2*4)+(1*2)=135
135 % 10 = 5
So 1221793-42-5 is a valid CAS Registry Number.
1221793-42-5Relevant articles and documents
Substituted piperidine amide derivative, preparation method thereof, and application of derivative to pharmacy
-
, (2017/08/30)
The invention relates to a substituted piperidine amide derivative as shown in a general formula (I) or a stereisomer and pharmaceutically acceptable salt thereof, a preparation method of the derivative, medicinal combination as well as application of the derivative to the aspects of local anaesthesia or analgesia. The definition of each group of the general formula (I) is consistent with that of the description. (The general formula (I) is as shown in the description).
COMBINATIONS OF HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 528; 529, (2015/02/02)
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
INHIBITORS OF HEPATITIS C VIRUS
-
Page/Page column 102, (2012/01/05)
The present application includes novel inhibitors of HCV, compositions containing such compounds, therapeutic methods that include the administration of such compounds.
